Piperlongumine, a novel treatment option to overcome BRAF inhibitor resistance in melanoma

被引：0
|
作者：
Ramachandran, Sharavan [1 ]
Fofaria, Neel [1 ]
Srivastava, Sanjay [1 ]
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, Amarillo, TX USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-3518
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3518
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Role Played by Signalling Pathways in Overcoming BRAF Inhibitor Resistance in Melanoma
    Chan, Xian Yang
    Singh, Alamdeep
    Osman, Narin
    Piva, Terrence J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (07)
  • [42] Modeling BRAF inhibitor resistance in genetically engineered mouse models of melanoma
    Kwong, Lawrence N.
    Jiang, Shan
    Chin, Lynda
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [43] BRAF inhibitor resistance is mediated by N-Ras upregulation in melanoma
    Ahn, Jun-Ho
    Lee, Michael
    FASEB JOURNAL, 2014, 28 (01):
  • [44] TARGETING BAG-1-MEDIATED PROTEIN INTERACTIONS TO OVERCOME BRAF INHIBITOR RESISTANCE
    Enthammer, Marion
    Thurner, Marco
    Khalid, Sana
    Stuppner, Hermann
    Cutress, Ramsey I.
    Troppmair, Jakob
    ANTICANCER RESEARCH, 2014, 34 (10) : 6219 - 6219
  • [45] Combination Treatment Strategies to Overcome PARP Inhibitor Resistance
    Soung, Young-Hwa
    Chung, Jun
    BIOMOLECULES, 2023, 13 (10)
  • [46] Novel BRAF inhibitor chemotherapy shows high success rate in melanoma
    不详
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (10) : 1524 - 1524
  • [47] Repurposing Melanoma Chemotherapy to Activate Inflammasomes in the Treatment of BRAF/MAPK Inhibitor Resistant Melanoma
    Ahmed, Farzana
    Tseng, Hsin-Yi
    Ahn, Antonio
    Gunatilake, Dilini
    Alavi, Sara
    Eccles, Michael
    Rizos, Helen
    Gallagher, Stuart J.
    Tiffen, Jessamy C.
    Hersey, Peter
    Al Emran, Abdullah
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (05) : 1444 - +
  • [48] Novel BRAF inhibitor chemotherapy shows high success rate in melanoma
    不详
    PHARMACOGENOMICS, 2010, 11 (10) : 1351 - 1351
  • [49] Identification of NRAS isoform 2 overexpression as a novel mechanism facilitating BRAF inhibitor resistance in malignant melanoma (MM)
    Duggan, Megan
    Stiff, Andrew
    Salavaggione, Gonzalo Olaverria
    Bainazar, Maryam
    Latchana, Nicholas
    Markowitz, Joseph
    de la Chapelle, Albert
    Eisfeld, Ann-Kathrin
    Carson, William
    CANCER RESEARCH, 2016, 76
  • [50] An Unholy Alliance: Cooperation between BRAF and NF1 in Melanoma Development and BRAF Inhibitor Resistance
    Gibney, Geoffrey T.
    Smalley, Keiran S. M.
    CANCER DISCOVERY, 2013, 3 (03) : 260 - 263
12345